ArticleCardiology research2022
Effect of Sex on Neutrophil to Lymphocyte Ratio and Coronary Flow in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.
Article in Cardiology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFemale patients show poorer outcomes after coronary interventions compared to males. This study aims to investigate the role of enhanced inflammatory response in female ST-elevation myocardial infarction (STEMI) patients in poor outcomes post primary percutaneous coronary intervention (PPCI).
methodsThis study included 120 STEMI patients who went to PPCI in two tertiary cardiac centers over 6 months. All STEMI patients who are eligible for PPCI are included. We excluded those who had previous coronary artery bypass grafting (CABG) with venous grafts, previous PCI with in-stent restenosis (ISR), and those who had signs of infection on admission. These are then divided into two groups according to sex (males and females). Impaired coronary flow (also known as no-reflow) is defined as a coronary TIMI (thrombolysis in myocardial infarction) flow less than 3 after PCI in the absence of mechanical coronary occlusion.
resultsThe studied groups included 88 males and 32 females. The median age in females was higher than males (62 vs. 57.5 years respectively, P = 0.005). The prevalence of hypertension (34 vs. 21 patients, P = 0.01), non-insulin-dependent diabetes mellitus (NIDDM) (22 vs. 16 patients, P = 0.01) and smoking (61 vs. 0 patients, P < 0.001) was higher in male patients. The incidence of impaired coronary flow did not differ significantly between the two groups (10 males and six females, P = 0.363). The median neutrophil to lymphocyte (N/L) ratio showed to be non-significantly higher in females (5 in males vs. 6 in females, P = 0.342). However, the mean N/L ratio was significantly higher in female patients with impaired coronary flow compared to males (9.35 vs. 5.79, P = 0.003).
conclusionsThe enhanced inflammatory response in female STEMI patients may be responsible for poorer outcomes after PPCI. Larger-scale studies are required to define immune mechanisms as a potential target to improve outcomes in STEMI patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.